REZPLEN

This brand name is authorized in Mexico.

Active ingredients

The drug REZPLEN contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII CC995ZMV90 - AMBROXOL HYDROCHLORIDE
 

Ambroxol induces activation of the surfactant system by acting directly on the type II pneumocytes of the alveoles and the Clara cells in the region of the small airways. It promotes the formation and outward transfer of surface-active material in the alveolar and bronchial region of the foetal and adult lungs.

 
Read more about Ambroxol
2
UNII H1250JIK0A - CLARITHROMYCIN
 

Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria.

 
Read more about Clarithromycin

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
MX Comisión Federal para la Protección contra Riesgos Sanitarios 531M2003, 616M2004

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.